Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Drinks Industry News Technology Industry News Route Mobile automates customer experience for Coca-Cola UAE Route Mobile Limited, a Communication Platform as a Service (CPaaS) provider, said that its step-down subsidiary has helped… bySrinathJune 30, 2022
